Valeritas – $53 Million IPO

New York – April 7, 2017 – Cooley advised the underwriters on Valeritas Holdings’ $52.5 million initial public offering of 5,250,000 shares of common stock. The underwriters have a 30-day option to purchase an additional 787,500 shares.    

Cowen and Company and Wedbush PacGrow acted as joint book-running managers for the offering. Roth Capital Partners and B Riley & Co acted as co-managers.

Valeritas, which is headquartered in Bridgewater, New Jersey, and trades on The NASDAQ Capital Market under “VLRX,” is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. 

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.


Related Contacts
Div Gupta Partner, New York
Brent Siler Partner, Washington, DC
Brian Leaf Partner, Reston
Mark Ballantyne Associate, Reston
Natasha Leskovsek Partner, Washington, DC
Sarah diFrancesca Partner, New York
Bill Christiansen Partner, Seattle
Aaron Nudelman Associate, Seattle
Stephanie Gentile Partner, New York
Darren DeStefano Partner, Reston